These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

476 related items for PubMed ID: 32081489

  • 1. Natural History of Geographic Atrophy Secondary to Age-Related Macular Degeneration: Results from the Prospective Proxima A and B Clinical Trials.
    Holekamp N, Wykoff CC, Schmitz-Valckenberg S, Monés J, Souied EH, Lin H, Rabena MD, Cantrell RA, Henry EC, Tang F, Swaminathan B, Martin J, Ferrara D, Staurenghi G.
    Ophthalmology; 2020 Jun; 127(6):769-783. PubMed ID: 32081489
    [Abstract] [Full Text] [Related]

  • 2. Characterizing Disease Burden and Progression of Geographic Atrophy Secondary to Age-Related Macular Degeneration.
    Chakravarthy U, Bailey CC, Johnston RL, McKibbin M, Khan RS, Mahmood S, Downey L, Dhingra N, Brand C, Brittain CJ, Willis JR, Rabhi S, Muthutantri A, Cantrell RA.
    Ophthalmology; 2018 Jun; 125(6):842-849. PubMed ID: 29366564
    [Abstract] [Full Text] [Related]

  • 3. Müller cells and choriocapillaris in the pathogenesis of geographic atrophy secondary to age-related macular degeneration.
    Pilotto E, Midena E, Longhin E, Parrozzani R, Frisina R, Frizziero L.
    Graefes Arch Clin Exp Ophthalmol; 2019 Jun; 257(6):1159-1167. PubMed ID: 30903311
    [Abstract] [Full Text] [Related]

  • 4. Macular Atrophy in the HARBOR Study for Neovascular Age-Related Macular Degeneration.
    Sadda SR, Tuomi LL, Ding B, Fung AE, Hopkins JJ.
    Ophthalmology; 2018 Jun; 125(6):878-886. PubMed ID: 29477692
    [Abstract] [Full Text] [Related]

  • 5. Emixustat Hydrochloride for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Clinical Trial.
    Rosenfeld PJ, Dugel PU, Holz FG, Heier JS, Pearlman JA, Novack RL, Csaky KG, Koester JM, Gregory JK, Kubota R.
    Ophthalmology; 2018 Oct; 125(10):1556-1567. PubMed ID: 29716784
    [Abstract] [Full Text] [Related]

  • 6. Reticular pseudodrusen: a risk factor for geographic atrophy in fellow eyes of individuals with unilateral choroidal neovascularization.
    Finger RP, Wu Z, Luu CD, Kearney F, Ayton LN, Lucci LM, Hubbard WC, Hageman JL, Hageman GS, Guymer RH.
    Ophthalmology; 2014 Jun; 121(6):1252-6. PubMed ID: 24518615
    [Abstract] [Full Text] [Related]

  • 7. Association of Lesion Location and Functional Parameters with Vision-Related Quality of Life in Geographic Atrophy Secondary to Age-related Macular Degeneration.
    Künzel SH, Broadbent E, Möller PT, Lindner M, Goerdt L, Czauderna J, Schmitz-Valckenberg S, Holz FG, Pfau M, Fleckenstein M.
    Ophthalmol Retina; 2024 Aug; 8(8):794-803. PubMed ID: 38311207
    [Abstract] [Full Text] [Related]

  • 8. The development of choroidal neovascularization in eyes with the geographic atrophy form of age-related macular degeneration.
    Sunness JS, Gonzalez-Baron J, Bressler NM, Hawkins B, Applegate CA.
    Ophthalmology; 1999 May; 106(5):910-9. PubMed ID: 10328389
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of reticular macular disease.
    Pumariega NM, Smith RT, Sohrab MA, Letien V, Souied EH.
    Ophthalmology; 2011 Aug; 118(8):1619-25. PubMed ID: 21550118
    [Abstract] [Full Text] [Related]

  • 10. Role of flicker perimetry in predicting onset of late-stage age-related macular degeneration.
    Luu CD, Dimitrov PN, Robman L, Varsamidis M, Makeyeva G, Aung KZ, Vingrys AJ, Guymer RH.
    Arch Ophthalmol; 2012 Jun; 130(6):690-9. PubMed ID: 22801825
    [Abstract] [Full Text] [Related]

  • 11. Visual Function Decline Resulting from Geographic Atrophy: Results from the Chroma and Spectri Phase 3 Trials.
    Heier JS, Pieramici D, Chakravarthy U, Patel SS, Gupta S, Lotery A, Lad EM, Silverman D, Henry EC, Anderesi M, Tschosik EA, Gray S, Ferrara D, Guymer R, Chroma and Spectri Study Investigators.
    Ophthalmol Retina; 2020 Jul; 4(7):673-688. PubMed ID: 32199866
    [Abstract] [Full Text] [Related]

  • 12. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: one-year results of 2 randomized clinical trials--TAP report. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group.
    Arch Ophthalmol; 1999 Oct; 117(10):1329-45. PubMed ID: 10532441
    [Abstract] [Full Text] [Related]

  • 13. Risk characteristics of the combined geographic atrophy and choroidal neovascularisation phenotype in age-related macular degeneration.
    Saade C, Ganti B, Marmor M, Freund KB, Smith RT.
    Br J Ophthalmol; 2014 Dec; 98(12):1729-32. PubMed ID: 25091949
    [Abstract] [Full Text] [Related]

  • 14. Association Between the Cilioretinal Artery and Choroidal Neovascularization in Age-Related Macular Degeneration: A Secondary Analysis From the Age-Related Eye Disease Study.
    Snyder K, Yazdanyar A, Mahajan A, Yiu G.
    JAMA Ophthalmol; 2018 Sep 01; 136(9):1008-1014. PubMed ID: 29978186
    [Abstract] [Full Text] [Related]

  • 15. Incident choroidal neovascularization in fellow eyes of patients with unilateral subfoveal choroidal neovascularization secondary to age-related macular degeneration: SST report No. 20 from the Submacular Surgery Trials Research Group.
    Submacular Surgery Trials Research GroupJohns Hopkins University School of Medicine, 550 N Broadway, Ste 115, Baltimore, MD 21205-2005, USA. nmboffice@jhmi.edu, Solomon SD, Jefferys JL, Hawkins BS, Bressler NM.
    Arch Ophthalmol; 2007 Oct 01; 125(10):1323-30. PubMed ID: 17923538
    [Abstract] [Full Text] [Related]

  • 16. Visual acuity and contrast sensitivity in patients with neovascular age-related macular degeneration. Results from the Radiation Therapy for Age-Related Macular Degeneration (RAD-) Study.
    Bellmann C, Unnebrink K, Rubin GS, Miller D, Holz FG.
    Graefes Arch Clin Exp Ophthalmol; 2003 Dec 01; 241(12):968-74. PubMed ID: 13680248
    [Abstract] [Full Text] [Related]

  • 17. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration.
    Sunness JS, Gonzalez-Baron J, Applegate CA, Bressler NM, Tian Y, Hawkins B, Barron Y, Bergman A.
    Ophthalmology; 1999 Sep 01; 106(9):1768-79. PubMed ID: 10485549
    [Abstract] [Full Text] [Related]

  • 18. Verteporfin therapy of subfoveal choroidal neovascularization in patients with age-related macular degeneration: additional information regarding baseline lesion composition's impact on vision outcomes-TAP report No. 3.
    Bressler NM, Arnold J, Benchaboune M, Blumenkranz MS, Fish GE, Gragoudas ES, Lewis H, Schmidt-Erfurth U, Slakter JS, Bressler SB, Manos K, Hao Y, Hayes L, Koester J, Reaves A, Strong HA, Treatment of Age-Related Macular Degeneration with Photodynamic Therapy (TAP) Study Group.
    Arch Ophthalmol; 2002 Nov 01; 120(11):1443-54. PubMed ID: 12427056
    [Abstract] [Full Text] [Related]

  • 19. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration.
    Sunness JS, Rubin GS, Broman A, Applegate CA, Bressler NM, Hawkins BS.
    Ophthalmology; 2008 Sep 01; 115(9):1480-8, 1488.e1-2. PubMed ID: 18486216
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and Safety of Lampalizumab for Geographic Atrophy Due to Age-Related Macular Degeneration: Chroma and Spectri Phase 3 Randomized Clinical Trials.
    Holz FG, Sadda SR, Busbee B, Chew EY, Mitchell P, Tufail A, Brittain C, Ferrara D, Gray S, Honigberg L, Martin J, Tong B, Ehrlich JS, Bressler NM, Chroma and Spectri Study Investigators.
    JAMA Ophthalmol; 2018 Jun 01; 136(6):666-677. PubMed ID: 29801123
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.